PEC vs Syngen Biotech: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Syngen Biotech (8279) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Syngen Biotech

0%+108%-24%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYSyngen BiotechYoY
Oct 2026NT$2.84 billion+102.0%NT$193.4 million+12.3%
Sep 2026NT$2.64 billion+100.0%NT$201.4 million-7.8%
Aug 2026NT$2.62 billion+105.4%NT$178.7 million+0.6%
Jul 2026NT$2.51 billion+92.6%NT$178.1 million+6.6%
Jun 2026NT$2.33 billion+94.9%NT$176.6 million+6.0%
May 2026NT$2.46 billion+108.5%NT$182.5 million-10.8%
Apr 2026NT$2.06 billion+68.3%NT$234.4 million-0.8%
Mar 2026NT$1.94 billion+64.4%NT$149.1 million-24.2%
Feb 2026NT$1.6 billion+56.7%NT$138.1 million-17.7%
Jan 2026NT$1.58 billion+49.8%NT$129.5 million+6.6%
Dec 2025NT$1.92 billion+69.9%NT$167.7 million+8.3%
Nov 2025NT$1.55 billion+53.0%NT$139.9 million-17.7%
Oct 2025NT$1.4 billion+53.6%NT$172.2 million+14.8%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16